CERTARA INC. - COMMON STOCK

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

16 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Certara Reports Fourth Quarter 2023 Financial Results

29 фев 2024 16:10:01 Источник Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

01 фев 2024 16:30:00 Источник Nasdaq GlobeNewswire

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

13 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  

21 ноя 2023 16:30:00 Источник Nasdaq GlobeNewswire

Certara Reports Third Quarter 2023 Financial Results

08 ноя 2023 16:10:01 Источник Nasdaq GlobeNewswire

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

11 окт 2023 16:15:00 Источник Nasdaq GlobeNewswire

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

19 сен 2023 08:15:00 Источник Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

29 авг 2023 16:15:00 Источник Nasdaq GlobeNewswire

Certara Simcyp™ Group Awarded Two New Grants from US FDA

29 авг 2023 08:15:00 Источник Nasdaq GlobeNewswire

Certara Reports Second Quarter 2023 Financial Results

09 авг 2023 16:15:01 Источник Nasdaq GlobeNewswire

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

13 июл 2023 16:30:00 Источник Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

02 июн 2023 16:15:00 Источник Nasdaq GlobeNewswire

Certara Reports First Quarter 2023 Financial Results

08 май 2023 16:15:00 Источник Nasdaq GlobeNewswire

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year

27 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire

Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference

10 апр 2023 16:30:00 Источник Nasdaq GlobeNewswire

A.I. Coming to Certara’s D360 Scientific Informatics Software

09 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

07 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Certara Reports Fourth Quarter and Full Year 2022 Financial Results

01 мар 2023 16:16:01 Источник Nasdaq GlobeNewswire

Certara Announces Transition Plan for Chief Financial Officer

01 мар 2023 16:15:00 Источник Nasdaq GlobeNewswire